We' ll to wait and see. I got it
as a news mail alert!
Anyway, there was no promise for
any news, just an overview as
was specified:
Key Highlights:
Approximately $18 million upfront and milestone payments received to date
Developing cannabinoid-based treatments for cancer, inflammatory, autoimmune, and metabolic diseases
Advanced clinical stage drug development company with a compelling platform technology
Highly experienced management, clinical, and regulatory team
News 
Market Data 
Discover 
